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Campylobacter jejuni is one of the most common food-borne pathogens, and chickens are the main source of these bacteria. Fowls and birds in general are prone to C. jejuni colonization more than any other animals (Sahin et al. 2001) . Chickens are usually colonized by C. jejuni within 5-6 weeks of age and remain as a reservoir throughout their lifespan. Campylobacteriosis is the most commonly reported zoonosis (EFSA 2015) . To reduce human infections with Campylobacters, it is necessary to reduce the colonization in the chickens (Cisek and Binek 2014) . Modern broiler rearing has taken attention to natural substances which can help them maintain healthy status of fowls. Therefore, farmers, breeders have been looking for probiotic microbiota. In poultry breeding probiotic strains of the genus Lactobacillus are commercially mostly used (Cisek and Binek 2014) ; Bacillus spp. are also frequently used (Novak et al. 2011) ; at recent time representatives of the genus Enterococcus have also been reported especially in relation with immunological parameters (Stasova et al. 2015; Karaffova et al. 2017) . The probiotic strains of the last mentioned genus, however, usually show a broad antimicrobial acitivity against both, Gram-positive and Gramnegative causative bacteria and this is associated with the production of bacteriocins − enterocins (Laukova et al. 2004a; Franz et al. 2007; Scerbova and Laukova 2016) . Bacteriocins are antimicrobial proteinaceous substances produced by some bacteria to kill other more or less related bacteria (Franz et al. 2007) . Their beneficial effect in food-producing animal husbandries was previously shown e.g. in rabbits (Szaboova et al. 2011; Laukova et al. 2012 ) but beneficial effects due to enterocin-producing strains were also reported (Laukova et al. 2003a (Laukova et al. , 2015 Pogany Simonova et al. 2013) . Enterococcus faecium AL41 is our environmental strain previously more detailedly characterized in our laboratory (Laukova et al. 1998 (Laukova et al. , 2004b ; it is known to produce a new type of enterocin named enterocin M, which is very similar to enterocin P (Marekova et al. 2007) . It was deponed to the Czech Culture Collection of Microorganisms in Brno, Czech Republic (CCM8558). Its beneficial effect was checked not only in animals but also in animal-derived food such as in sausage (Laukova et al. 2003b) . Because of complex information we decided to use it in chickens challenged with Campylobacter jejuni to reach results for its recommendation and inclusion in a further probiotic product.
MATERIAL AND METHODS
Strains preparation. An enterocin M-producing strain E. faecium CCM8558 (AL41) possessing probiotic properties was prepared as previously referred to by Laukova et al. (2015) . The strain CCM8558 was grown in De Mann-Rogose-Sharpe broth (MRS; Merck, Germany) for 18 h at 37°C. Broth culture was centrifuged at 10 000 g (at 4°C) for 30 min. Supernatant was removed and cells of CCM8558 strain were re-suspended in Ringer solution (Merck) to achieve the concentration of 10 9 colony forming units per ml (CFU/ml). The concentration of CCM8558 cells was checked by dilutions spread on M-Enterococcus agar (Becton and Dickinson, USA) according to the International Organization for Standardization (ISO 7899) and expressed in CFU/ml. Before application but also after CCM8558 isolation from gastrointestinal tract (GIT), its identity was confirmed by polymerase chain reaction (PCR) analysis (Woodford et al. 1997) and by the MALDI-TOF identification system as well (Alatoom et al. 2011) . To distinguish E. faecium CCM8558 strain from the other enterococci in the samples, CCM8558 strain treated with rifampicin (100 µg/ml) was used .
Campylobacter jejuni CCM6191 (supplied by the Czech Culture Collection, Brno, Czech Republic) was grown on Campylobacter agar base Karmali CM0935 with supplement SR0167 (Oxoid Ltd., UK) in the jar with microaerophilic atmospheare (CampyGen, Oxoid Ltd.) placed in an incubator at 42°C for 2 days. Broth culture of Campylobacter jejuni CCM6191 was prepared in Brian Heart broth (Difco Laboratories Inc., USA) under the former mentioned condition; triplet of tubes was prepared. Final cells concentration of Campylobacter jejuni CCM6191 was 10 8 CFU/ml. After its isolation from passaging in the gastrointestinal tract, its identity was checked by the MALDI-TOF identification system again.
Experimental design. Forty chicks (1-day-old, Cobb 500 breed) were used in the experiment. The experiment lasted for 11 days. Chicks were placed in large pens with cellulose cotton (Pehazell, Slovakia) and reared under the regimen 23 h light and 1 h darkness, initial room temperature 32-33°C was reduced weekly by 1°C to a final temperature 28°C. Relative humidity was within a range of 50-60%. Birds had free acces to feed (BR1 -starter diet) and doi: 10.17221/12/2017-CJAS water. Application of cleaning and feeding regimens prevented them from cross-contamination effectively throughout the experiment. Chicks were randomly divided into four groups per 10 chicks each (n = 10): control (CG), E. faecium CCM8558 (EG1), combined E. faecium CCM8558 + C. jejuni CCM6191 (EG2), and C. jejuni CCM6191 (EG3). E. faecium CCM8558 at concentration 10 9 CFU/ml (200 µl) in Ringer solution was administered daily per os to the groups EG1 and EG2 for 7 days of the experiment (from day 0-1). Experimental infection of C. jejuni CCM6191 (EG3) and CCM8558 + C. jejuni CCM6191 (EG2) groups was carried out individually per os on day 4 of the experiment (C. jejuni CCM6191, concentration 10 8 CFU/ml in Ringer solution) as a single dose 200 µl. For microbiota evaluation, faecal mixtures (n = 5) were sampled on day 0-1 (from each group of birds, 1 st sampling), on day 7 (2 nd sampling), and on day 11 (3 rd sampling) (it means on day 7 of CCM8558 application, day 4 Campylobacter postinfection, and on day 4 of CCM8558 cessation, day 7 post-infection). Moreover, at those times, five birds from each group were sacrificed using intraperitoneal injection of xylasine (Rometar 2%; Spofa, Czech Republic) at a dose 0.6 ml/kg and ketamine (Narkamon 5%; Spofa) at a dose 0.7 ml/kg (Levkut et al. 2012) ; caecal and liver contents were sampled to check microbiota.
Microbial analyses. The standard microbiological method (ISO, International Organization for Standardization) was used, dilutions in Ringer solution 1 : 9 (Merck) by mixing using Stomacher (Masticator, Spain). Dilutions were spread onto appropriate selective media as follows: E. faecium CCM8558 strain was determined on M-Enterococcus agar (Difco Laboratories Inc.) enriched with rifampicin; the total enterococcal count was determined on M-Enterococcus agar (method No. 7889). Campylobacter agar base Karmali CM0935 with supplement SR0167 (Oxoid Ltd.) was used to count Campylobacter spp. placed in the jar with microaerophilic atmosphere (CampyGen, Oxoid Ltd.) and in the incubator. Coliform bacteria were counted on MacConkey agar (Becton and Dickinson), Salmonella sp. were precultivated in Rappaport-Vassiliadis broth (Merck) and then spread onto Brillant Green agar (Becton and Dickinson). Bacteria were cultivated at 37°C for 18-24 h. Campylobacter spp. were cultivated at 42°C for 2 days. The bacterial counts were expressed in CFU/g (± SD).
Biochemical analyses, phagocytic activity, gluthatione-peroxidase test. On days 7 and 11 (that is, on day 7 of CCM8558 application, day 4 post-infection with Campylobacter, day 4 of CCM8558 cessation, day 7 post-infection) blood was sampled into heparinized and/or unheparinized tubes (following blood analyses) by intracardial punction (n = 5). Phagocytic activity (PA) was measured by a direct counting procedure using microspheric hydrophilic particles (MSHPs). Ingestion of MSHPs by polymorphonuclear cells was described by Vetvicka et al. (1982) . Blood smears were stained with May-Gruenwald and Giemsa-Romanowski stains. PA was calculated as the number of white cells containing at least three engulfed particles per 100 white cells (neutrophils) and expressed in percentage. Index of PA (IPA) was calculated as the number of engulfed particles per total number of neutrophils observed. The percentage of phagocytic cells was evaluated using an optical microscope, by counting polymorphonuclear cells up to 100.
The enzyme glutathione-peroxidase (GPx) was determined using a Ransel kit (Randox Laboratories, Ltd., UK), expressed in U/gHb ± SD.
To test the biochemical parameters such as the total proteins (g/l), albumins (g/l), creatinine (µmol/l), triglycerides (mmol/l), total cholesterol (mmol/l), alanine aminotransferase (ALT) (µkat/l), aspartate aminotransferase (AST) (µkat/l), total cholesterol (mmol/l), α-amylase (µkat/l), calcium (mmol/l), phosphorus (mmol/l), and magnesium, a commercial kit Dialab (Czech Republic) and an analyzer ELLIPSE (AMS, Italy) were used; blood was sampled into nonheparinized sterile Eppendorf tubes. Blood serum was received by centrifugation at 3000 g for 10 min and stored frozen in plastic vials until analysis.
The experiment was carried out in accordance with the established standards for use of animals (Guide for the Care and Use of Laboratory Animals) and the experimental schedule was approved by the Ethic Commission of the University of Veterinary Medicine and Pharmacy in Košice, Institute of Animal Physiology, Slovak Academy of Sciences and approved by the Slovak Veterinary and Food Administration.
Statistical analysis. Statistical significance was assessed using one-way analysis of variance with the post hoc Tukey's multiple comparison test (one-way ANOVA). Probability values of less than 0.05 were considered siginificant.
RESULTS
On day 7 (2 nd sampling, Table 1 ), E. faecium CCM8558 reached in faeces of EG1 (CCM8558) and EG2 chickens (CCM8558 + C. jejuni CCM6191) up to 5.0 (log 10) CFU/g; it indicates a sufficient colonization of CCM8558 strain in the digestive tract of broiler chickens. Significantly higher counts of CCM8558 strain in chickens of EG1and EG2 (day 7 of application, day 4 post-infection, 2 nd sampling) were found compared to its counts on day 11 (3 rd sampling, day 4 of CCM8558 cessation, day 7 post-infection, a : a, P < 0.05). Moreover, almost the same counts of CCM8558 strain as in faeces were determined in caecum of EG1 and EG2 (Table 2, 2 nd sampling). Higher counts of CCM8558 were noted in EG1 at 3 rd sampling compared to its count in EG1 at 2 nd sampling (Table 2) . PCR analysis using primers and MALDI-TOF identification confirmed its identity (E. faecium). In liver, CCM8558 was not detected (Table 3) .
Enterococci in faeces of EG1 chicks (CCM8558) (3 rd sampling) were significantly higher (c : c, P < 0.01) compared to enterococci in EG1 (2 nd sampling); enterococci in EG3 (3 rd sampling) were significantly higher compared to enterococci in EG1 (2 nd sampling, P < 0.01). Enterococci in EG2 (3 rd sampling) were significantly higher compared to enterococci in EG1, EG3 (2 nd sampling, e : e, e : f, P < 0.01). Enterococci in caecum were not influenced; they reached almost the same counts as enterococci in faeces (Table 2 ). In liver, lower counts of enterococci were detected in EG2 at 3 rd sampling than in EG2 (2 nd sampling, a : a, P < 0.05, Table 3 ). Coliform bacteria in faeces, caecum or liver were not influenced by CCM8558 strain application (Tables 1-3 ). C. jejuni CCM6191 reached high counts in faeces of EG2 chicks (CCM8558 + C. jejuni CCM6191) post-infection as well as in EG3 group (C. jejuni CCM6191, Table 1 ); its initial inoculation was 8.0 CFU/ml; on day 7 (day 4 post-infection) CCM6191 reached up to (log 10) 6.0 CFU/g in EG2 and in EG4 up to 5.0 CFU/g. On day 11 (end of experiment, day 7 post-infection), C. jejuni CCM6191 counts in EG2 chicks reached still up to 5.0 (log10) CFU/g (Table 1 ). However, in faeces of EG2 (2 nd sampling) a tendency to reduce Campylobacters (day 7 of application, day 4 of infection) was found if compared to EG2 (3 rd sampling, day 11 -end of experiment, day 4 of cessation, day 7 post-infection; difference 1.21 log cycles) (Table 2), while in EG3 at this time (Table 2) ; in liver mostly less than 1.00 (log 10) CFU/g was detected (Table 3) .
No Salmonella cells were detected in chicken. At 2 nd sampling, PA values were significantly higher in infected groups (EG3, EG2; Table 4 ) compared to CG and EG1 (a : b, a : c, P < 0.01; d : b, d : c, P < 0.001). Significant increase in PA was also noted in EG2 and EG3 at 3 rd sampling compared to CG or EG1 (a : b, d : b, P < 0.01, P < 0.001; c : b, P < 0.01). Regarding the IPA, siginificant increase was noted in EG3 compared to CG, and in EG2 compared to CG, a : d, d : b, P < 0.05) at 3 rd sampling; i.e. in infected groups (Table 4) . (Table 5 ) comparing values of nitrogen profile (total proteins, albumin, creatinine), it can be concluded that initial hypoproteinaemia in all groups was noted comparing groups EG1, EG2, EG3 to CG (P < 0.001, P < 0.05, P < 0.05), hypoalbuminaemia, hypocreatinaemia (day 7); at the end of experiment, increase of these parameters in the experimental groups (EG1, EG2, EG3) was noted. In opposite, in blood serum of chickens of CG even at the end of experiment hypoproteinaemia and hypoalbuminaemia were noted.
Measured values of AST and ALT were in the framework of reference values. However, α-amylase values were low (Table 6 ). Regarding the triglycerides on day 4 of infection, slight lipidemia was measured. In all chickens hypocalcaemia was noted; in general, the values of minerals varied (Table 7) . At the end of experiment Mg values were increased in EG1 compared to EG2 (P < 0.01) and in EG1 compared to EG3 (P < 0.05, Table 7) .
The values of GPx were lower during the whole experiment in the experimental goups EG1 and EG2 compared to CG; which means a beneficial effect. In EG1 (CCM8558) and EG2 (CCM8558 + C. jejuni CCM6191) even at the end of experiment lower counts were noted compared to CG but also compared to EG3 (C. jejuni CCM6191) (Table 6 ). There in EG3 even higher counts of GPx were reached compared to all other groups. On the other hand, the lowest, stable GPx value was noted in EG1 (CCM8558); it means that CCM8558 strain did not evoke oxidative stress; however, in EG3 (C. jejuni) it was probably evoked. day 7 -2 nd sampling, day 11 -3 rd sampling, 1 st sampling was not checked; 1 st sampling, day 0-1 = start of experiment; 2 nd sampling, day 7 = Enterococcus faecium CCM8558 application, day 4 of Campylobacter jejuni infection; 3 rd sampling, day 11 = end of experiment, day 4 of CCM8558 cessation, day 7 post-infection; CG = control group, EG1 = CCM8558, EG2 = CCM8558 + C. jejuni CCM6191; EG3 = C. jejuni CCM6191; a : b (P < 0.001, P < 0.05, P < 0.05); reference values: total proteins 27-32 g/l; albumin 11.7-16.0 g/l; creatinine 11.1-30.6 µmol/l doi: 10.17221/12/2017-CJAS
DISCUSSION
As in our previous experiments using CCM8558 strain = AL41 (Laukova et al. , 2015 , here also sufficient colonization in the GIT of chickens was approved including those chickens infected with C. jejuni CCM6191 strain. Followed our previous studies (Herich et al. 2004; Laukova et al. 2015) anti-Campylobacter effect or anti-Salmonella or anti-coliforms effect was noted. In our study a tendency to reduce Campylobacter was also noted. Moreover, in our previous studies, antimicrobial effect of CCM8558 strain was achieved both in vitro and in vivo, but with a longer application period. It means, to observe the tendency to reduce Campylobacter could be more clearly documented by a longer application of CCM8558 strain in chickens. In spite of this, CCM8558 strain probably acts as a protective element; it seems that it does not damage the intestinal barrier (mucosa) and mucus which play an important role as a capture area to catch pathogenic strains (Ohland and MacNaughton 2010) . Glyconjugates, which are basic components of mucus, were probably beneficially influenced by E. faecium CCM8558. The strain with protective effect should not degrade mucin; this property seems to be associated with CCM8558 strain because it did not translocate in the liver; however, count of total enterococci in liver reached up to 10 2 or 10 3 CFU/g . Similarly, e.g. reported beneficial effect of E. faecium EF55 strain (producing enterocin 55) on the expression of MUC (intestinal mucin gene) and production of IgA + IEL (intraperitoneal lymphocytes) in caecum after injection with Salmonella.
Phagocytic activity is an essential component of the cellular innate immunity response and plays an important role in host defense against microbial infection. In the experimental groups, PA activity was significantly increased. In EG1 and EG2 this could be explained through the ability of CCM8558 strain to modulate the Toll-like receptors (TLRs) expression and in EG3 it could be explained via the ability of CCM8558 strain to modify the activation of MIF, IFN-β, MD-2, and CD14 molecules in chickens challenged with CCM6191 strain as reported by Karaffova et al. (2017) . Toll-like receptors are pattern recognition receptors that function as microbial infection sensors and are critical for the initiation of the innate inflammatory and adaptive immune response (Shang et al. 2008) . Based on the results of Kavulova et al. (unpublished) , E. faecium AL41 has probably an antibacterial effect on C. jejuni CCM6191 in the caecum mediated by stimulation of local gut immune response. It seems that E. faecium AL41 (CCM8558) can regulate inflammatory response in the intestine through the local regulation of IL-17 and TGF-β4 expression.
The effect of CCM8558 strain on biochemical blood parameters (e.g. cholesterol or triglycerides) could be explained possibly by the fact that E. faecium CCM8558 is a lactic acid producing microorganism, producing enzymes degrading bile, deconjugates it, and it can lead to lower pH. These changes could function by lowering of cholesterol or triglycerides (Bovdisova and Capcarova 2015) . Hypoproteinaemia, for example, could be explained by a lower administration of exogenous proteins than loss or reduction of proteins synthesis. Creatinine is a parameter of the condition of glomeral system. From the clinical point of view high levels of creatinine are dangerous; in our study, creatinine values were low or normal. A nitrogenous profile provides information related to possible changes in apetite of the animals. In growing chickens, α-amylase plays an important role and lack of endogenous amylase limits the utilization of starch and reduces nutrition potential of feed. In our study, differences were not significant. Regarding the mineral metabolism, it was insignificantly influenced, too.
GPx belongs to the most abundant antioxidant enzymes protecting cells from oxidative damage (Mangiapane et al. 2014 ). In our conditions, lower values were assessed in experimental groups with CCM8558 strain; it indicates that this additive did not evoke oxidative stress. Similarly, also e.g. after Enterococcus durans ED26E/7 application in broiler rabbits, this enzyme was not influenced negatively .
CONCLUSION
E. faecium CCM8558 sufficiently colonized the gastrointestinal tract of chickens. In faeces of EG2 (2 nd sampling, CCM8558 + C. jejuni CCM6191) a tendency to reduce Campylobacter spp. (day 7 of application, day 4 of infection) was noted as compared to EG2 (3 rd sampling, day 11, end of experiment, day 4 of cessation, day 7 post-infection; difference 1.21 log cycles); while in EG3 at this time CCM6191 strain counts were reduced neither in faeces, nor in caceum. PA values were significantly higher in infected groups compared to CG and EG1 (CCM8558 group). A significant increase in PA was also noted in EG2 and EG3 at 3 rd sampling compared to CG or EG1. Probiotic additive did not evoke oxidative stress, in spite of C. jejuni CCM6191 strain; but values of GPx were lower than in CG. Biochemical parameters were influenced to the reference levels.
